Synapse - Marc Ladanyi

Results (1330)

Clinical activity of mitogen-activated protein kinase (MAPK) inhibitors in patients with MAP2K1 (MEK1)-mutated metastatic cancers: A systematic review and meta-analysis

Meeting Abstract

Dankner, M.; Petrecca, S.; Fabi, F.; Nowakowski, A.; Rajadurai, C. V.; Rousselle, E.; Stein, A.; Bian, D. J.; Tai, P.; Belaiche, A.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Tumor-agnostic genomic and clinical analysis of solid tumors with BRAF fusions

Meeting Abstract

Chen, M. F.; Yang, S. R.; Tao, J.; Desilets, A.; Rosen, E.; Gong, Y.; Mullaney, K. A.; Kris, M. G.; Arcila, M. E.; Donoghue, M.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer

Meeting Abstract

Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Quantifying the growth of clinical actionability in precision oncology using OncoKB

Meeting Abstract

Suehnholz, S. P.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Zhang, H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Carrero, S.; Arcila, M. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Non-invasive diagnosis of brainstem gliomas in pediatric, adolescent, and young adult patients through cerebrospinal fluid cell-free DNA sequencing

Meeting Abstract

Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B.; Alano, T.; Doe-Tetteh, S.; Bouvier, N.; Li, S.; Stockfisch, E.; Huereca, C.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer

Journal Article

Ricciuti, B.; Elkrief, A.; Alessi, J.; Wang, X.; Li, Y.; Gupta, H.; Muldoon, D. M.; Bertram, A. A.; Pecci, F.; Lamberti, G.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma

Journal Article

Dermawan, J. K. T.; Nafa, K.; Mohanty, A.; Xu, Y.; Rijo, I.; Casanova, J.; Villafania, L.; Benhamida, J.; Kelly, C. M.; Tap, W. D.; more...
Cancer Research Communications (2023)

Fulltext@MSK | Save

Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification

Journal Article

Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study

Journal Article

Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
Journal for ImmunoTherapy of Cancer (2023)

Fulltext@MSK | Save

Overcoming barriers to tumor genomic profiling through direct-to-patient outreach

Journal Article

Doe-Tetteh, S. A.; Camp, S. Y.; Reales, D.; Crowdis, J.; Noronha, A. M.; Wolff, B.; Alano, T.; Galle, J.; Selcuklu, S. D.; Viale, A.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save